Skip to main content
Clinical Trials/NCT06611969
NCT06611969
Active, not recruiting
Not Applicable

Effects of Inspiratory Muscle Training As a Complement to Usual Training on Respiratory Function and Performance in Amateur Athletes

University of Valencia1 site in 1 country38 target enrollmentSeptember 26, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Amateur Athletes
Sponsor
University of Valencia
Enrollment
38
Locations
1
Primary Endpoint
Expiratory forced volume in first second
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The main objective of the study is to study the changes in FEV1 with the introduction of the specific inspiratory muscle training programme in the training programme of the popular athletes included. In addition, the secondary aims are to observe the differences in the respiratory capacities of the patients, in the vital signs, VO2 max, respiratory frequency and cardiac variability, as well as to assess the running performance of the participants.

Participants will be assigned to one of 2 study groups: IMT group (n=20) or not-IMT group (n=20) The IMT group will perform inspiratory muscle training in conjunction with the conventional marathon training plan. The not-IMT group will follow only the conventional marathon training plan. The study will be conducted over a 12 week period.

Registry
clinicaltrials.gov
Start Date
September 26, 2024
End Date
July 30, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Francisco Martínez Arnau

Associate Professor of Physiotherapy

University of Valencia

Eligibility Criteria

Inclusion Criteria

  • Individuals willing to follow the 16-week running training plan
  • Possibility of combining aerobic training with inspiratory muscle training
  • Previous half marathon runner

Exclusion Criteria

  • - Exclusive or professional dedication to athletics
  • Previous or current use of respiratory muscle training.
  • Inadequate or health risk physical condition
  • Significant chronic cardiorespiratory diagnoses (e.g. moderate-severe COPD).
  • Neurological, muscular or neuromuscular problems that interfere with the ability to participate in tests and training protocols.
  • Discontinuity in the performance of training.
  • A terminal illness or any other major medical contraindication
  • Lack of informed consent

Outcomes

Primary Outcomes

Expiratory forced volume in first second

Time Frame: Before starting the intervention and after its completion (12 weeks)

FEV1, in liters/second, assessed by spirometry

Secondary Outcomes

  • Hearth rate variability(From the beginning to the end of the programme, recorded on a daily basis.)
  • Hearth rate(From the beginning to the end of the programme, recorded on a daily basis.)
  • Respiratory rate(From the beginning to the end of the programme, recorded on a daily basis.)
  • Running performance(From the beginning to the end of the programme, recorded on a daily basis.)
  • Maximal inspiratory pressure(Before starting the intervention and after its completion (12 weeks))
  • Maximal consumption of oxygen(Before starting the intervention and after its completion (12 weeks))

Study Sites (1)

Loading locations...

Similar Trials